RPMI 1640 was developed by Moore and his co-workers at Roswell Park Memorial Institute in 1966 for the growth of human leukemia cells in monolayer or suspension cultures.
RPMI Media are "multipurpose" enriched media providing extensive applications for a broad spectrum of mammalian and hybridoma cells including: